89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 152 filers reported holding 89BIO INC in Q1 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,008,326 | -31.3% | 518,674 | -15.7% | 0.00% | 0.0% |
| Q2 2023 | $11,657,415 | +63.5% | 615,167 | +31.4% | 0.00% | 0.0% |
| Q1 2023 | $7,130,549 | -15.1% | 468,191 | -29.1% | 0.00% | 0.0% |
| Q4 2022 | $8,400,833 | +273.4% | 659,924 | +69.8% | 0.00% | +100.0% |
| Q3 2022 | $2,250,000 | +712.3% | 388,580 | +351.5% | 0.00% | – |
| Q2 2022 | $277,000 | +4.9% | 86,061 | +22.9% | 0.00% | – |
| Q1 2022 | $264,000 | +97.0% | 70,036 | +583.6% | 0.00% | – |
| Q4 2021 | $134,000 | -42.7% | 10,245 | -18.2% | 0.00% | – |
| Q2 2021 | $234,000 | -59.9% | 12,525 | -49.1% | 0.00% | – |
| Q1 2021 | $583,000 | +162.6% | 24,631 | +170.8% | 0.00% | – |
| Q4 2020 | $222,000 | -63.0% | 9,095 | -60.2% | 0.00% | – |
| Q4 2019 | $600,000 | – | 22,836 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orchard Capital Management, LLC | 551,879 | $7,025,420 | 2.36% |
| RA Capital Management | 8,955,410 | $114,002,369 | 2.31% |
| Cormorant Asset Management, LP | 2,550,000 | $32,462 | 2.17% |
| Deep Track Capital, LP | 3,850,000 | $49,010,500 | 2.06% |
| COMMODORE CAPITAL LP | 758,244 | $9,652 | 1.46% |
| Ikarian Capital, LLC | 454,000 | $5,779,419 | 1.39% |
| DAFNA Capital Management LLC | 324,173 | $4,126,722 | 1.16% |
| Parkman Healthcare Partners LLC | 332,880 | $4,237,562 | 1.13% |
| Boxer Capital, LLC | 1,400,000 | $17,822,000 | 0.94% |
| Orbimed Advisors | 3,658,869 | $46,577,402 | 0.89% |